Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
---|
12/18/2003 | US20030232802 Aryl and heteroaryl sulfonates |
12/18/2003 | US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases |
12/18/2003 | US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases |
12/18/2003 | DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents |
12/18/2003 | CA2485164A1 Organic catalyst with enhanced solubility |
12/17/2003 | EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
12/17/2003 | EP1370519A1 Synthetic excitatory amino acids |
12/17/2003 | EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators |
12/17/2003 | EP0902781B1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
12/17/2003 | CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer |
12/17/2003 | CN1462358A Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer |
12/17/2003 | CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids |
12/17/2003 | CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors |
12/16/2003 | US6664293 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia |
12/16/2003 | US6664269 Isoquinolinone derivatives |
12/16/2003 | US6664250 Lactam derivatives as antiarrhythmic agents |
12/11/2003 | WO2003101967A1 Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives by reacting levodopa with formaldehyde or formaldehyde precursors |
12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
12/11/2003 | WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
12/11/2003 | US20030229116 Enamine derivatives |
12/11/2003 | US20030229113 Keratinocyte growth inhibitors and hydroxamic acid derivatives |
12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
12/11/2003 | US20030229077 Nitrogen-containing heterocyclic compounds |
12/10/2003 | EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use |
12/10/2003 | EP1368340A1 Piperazine derivatives as melanocortin receptor agonists |
12/10/2003 | EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
12/10/2003 | EP1368032A1 Excitatory amino acid receptor antagonists |
12/10/2003 | CN1130199C Improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt |
12/04/2003 | WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
12/04/2003 | WO2003099818A1 Substituted quinazolinone compounds |
12/04/2003 | WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
12/04/2003 | WO2003099786A2 Aromatic sulfones and their medical use |
12/04/2003 | WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF |
12/04/2003 | WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
12/04/2003 | US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent |
12/04/2003 | US20030225122 2-(S)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1H-isoquinolin -2-yl)- propionamide for example; Alzheimer's disease or senile dementia |
12/04/2003 | US20030225071 N-heterocyclic amides and carbamates |
12/04/2003 | US20030225059 Cyclohexyl derivatives and their use as therapeutic agents |
12/04/2003 | CA2486966A1 Substituted quinazolinone compounds |
12/04/2003 | CA2486962A1 Compounds |
12/04/2003 | CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
12/03/2003 | EP1367055A1 Isoquinolinyl carboxamides and their use as anticonvulsants |
12/03/2003 | EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines |
12/03/2003 | EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai |
12/03/2003 | CN1460101A Novel compounds inhibiting factor Xa activity |
12/02/2003 | US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
11/27/2003 | WO2003097607A1 Tetrahydroisoquinoline derivatives |
11/27/2003 | WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
11/27/2003 | WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor |
11/27/2003 | WO2002100813A3 Modulators of peroxisome proliferator activated receptors |
11/27/2003 | US20030220498 Use of toxicologically benign iron salts or iron complexes as the catalysts, and commercially attractive aryl chlorides as well as various aryl sulfonates and aryl phosphonates can be used as starting materials |
11/27/2003 | US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
11/27/2003 | US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
11/27/2003 | US20030220349 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
11/27/2003 | US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling |
11/27/2003 | US20030220324 Substituted piperazines and methods of use |
11/27/2003 | US20030220318 New phenylalanine derivatives |
11/27/2003 | US20030220298 Combrestatin a-1 phosphate and combrestatin b-1 phosphate prodrugs |
11/27/2003 | CA2486764A1 Tetrahydroisoquinoline derivatives |
11/27/2003 | CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
11/26/2003 | EP1363907A2 Heterocycle carboxamides as antiviral agents |
11/26/2003 | EP1363873A2 Peptide deformylase inhibitors |
11/26/2003 | EP1363630A2 Kappa opioid receptor ligands |
11/26/2003 | CN1458149A Use of phenolic dauricine in preparing myocardial ischemia medicine |
11/26/2003 | CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors |
11/25/2003 | US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
11/25/2003 | US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides |
11/20/2003 | WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
11/20/2003 | WO2003095428A1 Dopamine receptor modulators as antipsychotic agents |
11/20/2003 | WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
11/20/2003 | WO2003094918A1 Substituted piperazine as melanocortin receptors ligands |
11/20/2003 | WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
11/20/2003 | US20030216569 Viricides; Aids therapy |
11/20/2003 | US20030216450 Inhibitors of dipeptidyl peptidase IV |
11/20/2003 | US20030216427 Amine derivatives for the treatment of apoptosis |
11/20/2003 | US20030216409 Heteroaryl alkyl piperazine derivatives |
11/20/2003 | US20030216396 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality, which are useful in the treatment of cancer, inflammation, osteoporosis and angiogenesis |
11/20/2003 | CA2485130A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
11/20/2003 | CA2484968A1 Substituted piperazine as melanocortin receptors ligands |
11/19/2003 | EP1362844A1 Benzylamine analogue |
11/19/2003 | EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect |
11/19/2003 | EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
11/19/2003 | EP0927165B1 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors |
11/13/2003 | WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
11/13/2003 | WO2003092695A1 Bicyclo 4.4.0 antiviral derivatives |
11/13/2003 | WO2003092688A2 Heterocyclic derivatives as opioid modulators |
11/13/2003 | WO2003029221A8 Tetrahydroisochinolines, their production and the use thereof as analgesics |
11/13/2003 | WO2003024448A3 Inhibitors of histone deacetylase |
11/13/2003 | WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases |
11/13/2003 | US20030212140 Analgesics; central nervous system disorders |
11/13/2003 | US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents |
11/13/2003 | CA2753371A1 Heterocyclic derivatives as opioid receptor modulators |
11/13/2003 | CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
11/12/2003 | EP1361216A1 Method of making a HIV-Protease inhibitor |
11/12/2003 | EP1206444B1 Compounds that inhibit tryptase activity |
11/12/2003 | EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
11/12/2003 | EP0923636B1 Color-safe bleach boosters, compositions and laundry methods employing same |
11/11/2003 | US6645979 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
11/11/2003 | US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors |
11/06/2003 | WO2003091688A2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes |